Skip to main content

Table 1 Characteristics of included studies and participants

From: Efficacy of cognitive remediation on activities of daily living in individuals with mild cognitive impairment or early-stage dementia: a systematic review and meta-analysis

Author, reference

Quality (PEDro score)

Participants

Country

Source of financial support

Study design

Health condition/diagnosis

Diagnostic criteria

Baseline cognitive status

MMSE score

Mean (SD)

Sample size (excluding drop outs)

Age (years)

Mean (SD)

Sex

Male/female

Education

Years (SD)

Barban et al. (2016) [43]

6

RCT (crossover design)

Probable early-stage AD

NINCDS-ADRDA

CDR: 1

TG: 23.4 (1.9)

CG: 23.4 (1.7)

TG: 42

CG: 39

TG: 76.7 (5.7)

CG: 76.9 (5.7)

TG: 13/29

CG: 11/28

TG: 8.8 (3.6)

CG: 9.2 (3.7)

Italy, Greece, Norway, and Spain

Co-funded by the European Union in the SOCIABLE project

Belleville et al. (2018) [33]

7

RCT (3-arm design)

MCI

Petersen’s diagnostic criteria for MCI

Not reported

TG1: 40

aTG2: 43

CG: 44

TG: 71.3 (8.5)

aTG2: 72.1 (6.7)

CG: 73.1 (6.5)

TG1: 20/20

aTG2: 19/24

CG: 18/26

TG1: 14.5 (4.2)

aTG2: 14.7 (3.5)

CG: 14.8 (3.8)

Canada

Funded by the Canadian Institutes for Health Research

Giuli et al. (2016) [41]

6

RCT (crossover design)

MCI

Petersen’s diagnostic criteria for MCI

TG: 25.7 (1.8)

CG: 25.8 (1.9)

TG: 48

CG: 49

TG: 76.0 (6.3)

CG: 76.5 (5.7)

TG: 17/31

CG: 19/30

TG: 6.7 (3.8)

CG: 5.3 (3.0)

Italy

Funded by the Italian Ministry of Health and the Marche Region

Probable early-stage (mild) AD

DSM-IV or NINCDS-ADRDA

TG: 20.2 (3.7)

CG: 20.3 (3.5)

TG: 48

CG: 47

TG: 76.5 (4.3)

CG: 78.7 (5.9)

TG: 19/29

CG: 13/34

TG: 5.9 (4.1)

CG: 4.5 (2.3)

Lam et al. (2015) [21]

6

RCT (4-arm design)

MCI

International Working Group on MCI diagnostic criteria

CDR: < 1

TG1: 25.7 (2.4)

TG2: 25.2 (2.2)

TG3: 25.8 (2.3)

CG: 25.6 (2.4)

TG1: 145

aTG2: 132

TG3: 147

bCG: 131

TG1: 74.4 (6.4)

aTG2: 76.3 (6.6)

TG3: 75.5 (6.7)

bCG: 75.4 (6.1)

TG1: 30/115

aTG2: 28/104

TG3: 34/113

bCG: 29/102

TG1: 3.9 (3.8)

aTG2: 3.4 (3.3)

TG3: 4.0 (3.6)

bCG: 4.0 (3.9)

Hong Kong

Funded by a donation from the Simon KY Lee Fund for the Elderly in Hong Kong

Law et al. (2019) [34]

7

RCT (4-arm design)

MCI

NIAAA criteria

Not reported

TG1: 15

aTG2: 16

TG3: 14

CG: 14

TG1: 76.9 (6.8)

aTG2: 77.9 (6.1)

TG3: 71.6 (7.4)

CG: 75.1 (8.5)

TG1: 7/8

aTG2: 8/8

TG3: 4/10

CG: 5/9

Not reported as average years

n (illiterate/primary/secondary/tertiary)

TG1: 4/6/5/0

aTG2: 5/3/7/0

TG3: 4/5/4/1

CG: 3/7/3/1

Hong Kong

Funded by the Research Grants Council (RGC) of the Hong Kong University Grants Committee

Law et al. (2022) [38]

7

RCT (4-arm design)

MCI

NIAAA criteria

Not reported

TG1: 38

aTG2: 37

aTG3: 34

CG: 36

TG1: 76.3 (7.2)

aTG2: 77.4 (6.7)

aTG3: 73.2 (7.3)

CG: 74.1 (7.5)

TG1: 13/25

aTG2: 16/21

aTG3: 11/23

CG: 12/24

Not reported as average years

n (illiterate/primary/secondary/tertiary)

TG1: 8/15/13/2

aTG2: 9/8/13/7

aTG3: 9/12/8/5

CG: 9/14/9/4

Hong Kong

The Research Grants Council, University Grants, Committee of Hong Kong, SAR, China

Muñiz et al. (2015) [22]

8

RCT (parallel design)

MCI or probable early-stage (mild) AD

Flicker et al. criteria for MCI

NINCDS-ADRDA

TG: 17.6 (0.7)

CG: 17.4 (1.0)

TG: 40

CG: 40

TG: 74.9 (1.1)

CG: 73.4 (1.0)

TG: 17/23

CG: 14/26

TG: 8.1 (0.6)

CG: 7.3 (4.4)

Spain

None described

Nousia et al. (2018) [40]

6

RCT (parallel design)

Probable early-stage (mild) AD

NINCDS-ADRDA

Not reported

TG: 25

CG: 25

TG: 76.2 (5.14)

CG: 76.3 (5.38)

TG: 9/16

CG: 5/20

TG: 8.08 (3.01)

CG: 8.92 (2.83)

Greece

None described

Pantoni et al. (2017) [35]

6

RCT (parallel design)

MCI

International Working Group on MCI diagnostic criteria

TG: 27.1 (2.6)

CG: 25.7 (3.2)

TG: 21

CG: 22

TG: 74.2 (6.0)

CG: 75.9 (7.6)

TG: 13/8

CG: 15/7

TG: 9.0 (5.3)

CG: 7.4 (3.0)

Italy

Funded by the Tuscany region and Italian Ministry of Health

Park (2022) [39]

7

RCT (parallel design

MCI

Petersen’s diagnostic criteria for MCI

MMSE Korean version

TG: 26.06 (1.34)

CG: 25.50 (1.31)

TG: 16

CG: 16

TG: 72.3 (5.13)

CG: 70.9 (4.51)

TG: 9/7

CG: 6/10

TG: 7.56 (3.93)

CG: 7.50 (2.89)

Korea

Ministry of Education of the Republic of Korea and the National Research Foundation of Korea

Rojas et al. (2013) [36]

4

RCT (parallel design)

MCI

Petersen’s diagnostic criteria for MCI

CDR: 0.5

TG: 27.53 (2.33)

CG: 27.13 (2.10)

TG: 15

CG: 15

TG: 72.0 (14.3)

CG: 76.9 (7.1)

TG: 9/6

CG: 8/7

TG: 10.53 (3.78)

CG: 10.53 (3.85)

Argentina

Co-funded by Ministry of Health of the city of Buenos Aires, Argentina, and CONICET

Rovner et al. (2018) [37]

6

RCT (parallel design)

MCI

NIAAA criteria

TG: 25.8 (2.3)

CG: 25.6 (2.5)

TG: 111

CG: 110

TG: 75.5 (7.1)

CG: 76.2 (6.90)

TG: 25/86

CG: 21/89

TG: 12.6 (2.2)

CG: 12.4 (2.9)

USA

Funded by the National Institute on Aging

Williams et al. (2014) [42]

6

RCT (3-arm design)

MCI or mild dementia

8-item ascertain dementia score > 2

TG 1: 25.6 (2.7)

aTG 2: 25.7 (2.7)

CG 2: 24.7 (3.1)

TG 1: 29

aTG 2: 28

CG 2: 32

TG 1: 86.0 (5.9)

aTG 2: 83.0 (10.5)

CG 2: 86.0 (4.8)

TG 1: 12/17

aTG 2: 6/22

CG 2: 11/21

TG 1: 13.30 (2.6)

aTG 2: 15.65 (1.8)

CG 2: 13.56 (2.4)

USA

Funded by the National Institute of Nursing Research and the National Institute of Deafness and Communication Disorders

  1. TG treatment group, CG control group, MCI mild cognitive impairment, AD Alzheimer’s disease, CDR clinical dementia rating score, RCT randomized control trial, SD standard deviation, DSM-IV American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, NIAAA the National Institute on Aging and Alzheimer’s Association, NINCDS-ADRDA National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s disease and Related Disorders Association, MMSE Mini-Mental State Examination, PEDro Physiotherapy Evidence Database
  2. aIntervention is not of interest to this review
  3. bControl group is an intervention of interest